MDT

Medtronic
D

MDT

Arincen70/100B
101.820
USD
-3.03
(-2.89%)
Pre Open
Last updated: · Delayed 15 min
Fair value103.28Plus-1%77Price 101.82180
Q2 FY2027 · Earnings report
EPS estimate 1.33Revenue estimate 9.48B
OverviewFinancialsNewsForecastEarningsDividendsCompany

Medtronic net income 1986–2027

Medtronic earned 1.47B USD in Q1 FY2027, the three months to 31 July 2026, up 41.3% on the same quarter a year before. Medtronic's net income over the last twelve months was 5.23B USD, up 12.2% on the twelve months before. In fiscal year 2026 it earned 4.80B USD, up 3.0% on the year before.

Last updated 6 Nov 2026 · Next report 24 Nov 2026

Net income

Net income · +3.1% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM31 Jul 20265.23B+12.21%13.93%37.54B
FY202624 Apr 20264.80B+2.96%13.20%36.36B
FY202525 Apr 20254.66B+26.82%13.90%33.54B
FY202426 Apr 20243.68B-2.18%11.36%32.36B
FY202328 Apr 20233.76B-25.42%12.03%31.23B
FY202229 Apr 20225.04B+39.74%15.90%31.69B
FY202130 Apr 20213.61B-24.70%11.97%30.12B
FY202030 Apr 20204.79B+3.41%16.56%28.91B
FY201926 Apr 20194.63B+49.19%15.16%30.56B
FY201827 Apr 20183.10B-22.94%10.36%29.95B
FY201728 Apr 20174.03B+13.85%13.56%29.71B
FY201629 Apr 20163.54B+32.26%12.27%28.83B
FY201530 Apr 20152.68B-12.72%13.20%20.26B
FY201425 Apr 20143.07B-11.60%18.02%17.01B
FY201330 Apr 20133.47B-4.15%20.90%16.59B
FY201230 Apr 20123.62B+16.83%22.35%16.18B
FY201130 Apr 20113.10B-0.10%19.43%15.93B
FY201030 Apr 20103.10B+42.88%19.59%15.82B
FY200930 Apr 20092.17B-2.78%14.86%14.60B
FY200830 Apr 20082.23B-20.38%16.51%13.52B
FY200730 Apr 20072.80B+10.02%22.78%12.30B
FY200630 Apr 20062.55B+41.18%22.55%11.29B
FY200530 Apr 20051.80B-7.93%17.94%10.05B
FY200430 Apr 20041.96B+22.47%21.56%9.09B
FY200330 Apr 20031.60B+62.58%20.87%7.67B
FY200230 Apr 2002984.00M-5.93%15.35%6.41B
FY200130 Apr 20011.05B-4.78%18.84%5.55B
FY200030 Apr 20001.10B+134.52%21.91%5.01B
FY199930 Apr 1999468.40M-21.22%11.33%4.13B
FY199830 Apr 1998594.60M+1.95%22.83%2.60B
FY199730 Apr 1997583.20M+36.17%23.92%2.44B
FY199630 Apr 1996428.30M+45.68%19.75%2.17B
FY199530 Apr 1995294.00M+26.51%16.87%1.74B
FY199430 Apr 1994232.40M+17.85%16.71%1.39B
FY199330 Apr 1993197.20M+22.11%14.85%1.33B
FY199230 Apr 1992161.50M+21.06%13.72%1.18B
FY199130 Apr 1991133.40M+22.72%13.06%1.02B
FY199030 Apr 1990108.70M+11.60%12.99%836.60M
FY198930 Apr 198997.40M+12.60%13.13%741.70M
FY198830 Apr 198886.50M+17.21%13.24%653.30M
FY198730 Apr 198773.80M+38.20%14.70%502.00M
FY198630 Apr 198653.40M—13.26%402.80M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Medtronic's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.